PT - JOURNAL ARTICLE AU - Brian Chang AU - Ram Sudhir Sharma AU - Trinh Huynh AU - Arshad Kudrolli TI - Aerial mucosalivary droplet dispersal distributions with implications for disease mitigation AID - 10.1101/2020.10.15.20213314 DP - 2020 Jan 01 TA - medRxiv PG - 2020.10.15.20213314 4099 - http://medrxiv.org/content/early/2020/10/20/2020.10.15.20213314.short 4100 - http://medrxiv.org/content/early/2020/10/20/2020.10.15.20213314.full AB - We investigate mucosalivary dispersal and deposition on horizontal surfaces corresponding to human exhalations with physical experiments under still-air conditions. Synthetic fluorescence tagged sprays with size and speed distributions comparable to human sneezes are observed with high-speed imaging. We show that while some larger droplets follow parabolic trajectories, smaller droplets stay aloft for several seconds and settle slowly with speeds consistent with a buoyant cloud dynamics model. The net deposition distribution is observed to become correspondingly broader as the source height H is increased, ranging from sitting at a table to standing upright. We find that the deposited mucosaliva decays exponentially in front of the source, after peaking at distance x = 0.71 m when H = 0.5 m, and x = 0.56 m when H = 1.5 m, with standard deviations ≈0.5 m. Greater than 99% of the mucosaliva is deposited within x = 2 m, with faster landing times further from the source. We then demonstrate that a standard nose and mouth mask reduces the mucosaliva dispersed by a factor of at least a hundred compared to the peaks recorded when unmasked.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by U.S. National Science Foundation COVID-19 RAPID Grant No. DMR-2030307.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:None required.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data is contained in the manuscript. http://physics.clarku.edu/~akudrolli/covid